Screener
Monte Rosa Therapeutics, Inc. GLUE Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s total revenue?
- Monte Rosa Therapeutics, Inc. (GLUE) reported total revenue of $8.97M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s total revenue changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s total revenue decreased by 61.3% year-over-year, from $23.19M to $8.97M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Monte Rosa Therapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude